Skip to main content
Erschienen in: Der Ophthalmologe 4/2013

01.04.2013 | CME Zertifizierte Fortbildung

Ätiologie und Pathogenese der altersabhängigen Makuladegeneration

verfasst von: P. Herrmann, F.G. Holz, P. Charbel Issa

Erschienen in: Die Ophthalmologie | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die altersabhängige Makuladegeneration (AMD) ist die häufigste Ursache für eine Erblindung in Deutschland. Aufgrund der demografischen Entwicklung ist zudem mit einer deutlichen Zunahme von Betroffenen zu rechnen. Neue Erkenntnisse zur Pathogenese der AMD wurden in den letzten Jahren durch molekularbiologische Methoden generiert, die insbesondere die Assoziation genetischer Faktoren mit der AMD herausstellten. Vor allem das Komplementfaktor-H-Gen sowie der zweite Hochrisiko-Locus ARMS2 sind maßgeblich am Risiko für die Erkrankung beteiligt. Normale Alterungsprozesse und Umwelteinflüsse wie Rauchen und erhöhte Lichtexposition modulieren das individuelle genetische Risikoprofil. Ein verbessertes Verständnis der komplexen AMD-Pathogenese ist auch in der augenärztlichen Praxis notwendig, um neue Therapien zu verstehen und den Patienten adäquat zu betreuen. In diesem Fortbildungsbeitrag soll eine Übersicht über das Zusammenspiel von Altern, externen Umwelteinflüssen und genetischen Faktoren bei der Entwicklung der AMD gegeben werden.
Literatur
1.
Zurück zum Zitat Vingerling JR, Klaver CC, Hofman A et al (1995) Epidemiology of age-related maculopathy. Epidemiol Rev 17:347–360PubMed Vingerling JR, Klaver CC, Hofman A et al (1995) Epidemiology of age-related maculopathy. Epidemiol Rev 17:347–360PubMed
2.
Zurück zum Zitat Sparrow JR, Nakanishi K, Parish CA (2000) The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 41:1981–1989PubMed Sparrow JR, Nakanishi K, Parish CA (2000) The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 41:1981–1989PubMed
3.
Zurück zum Zitat Holz FG, Sheraidah G, Pauleikhoff D et al (1994) Analysis of lipid deposits extracted from human macular and peripheral Bruch’s membrane. Arch Ophthalmol 112:402–406PubMedCrossRef Holz FG, Sheraidah G, Pauleikhoff D et al (1994) Analysis of lipid deposits extracted from human macular and peripheral Bruch’s membrane. Arch Ophthalmol 112:402–406PubMedCrossRef
4.
Zurück zum Zitat van der Schaft TL, Mooy CM, de Bruijn WC et al (1993) Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study. Br J Ophthalmol 77:657–661CrossRef van der Schaft TL, Mooy CM, de Bruijn WC et al (1993) Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study. Br J Ophthalmol 77:657–661CrossRef
5.
Zurück zum Zitat Schmitz-Valckenberg S, Steinberg JS, Fleckenstein M et al (2010) Combined confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography imaging of reticular drusen associated with age-related macular degeneration. Ophthalmology 117:1169–1176PubMedCrossRef Schmitz-Valckenberg S, Steinberg JS, Fleckenstein M et al (2010) Combined confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography imaging of reticular drusen associated with age-related macular degeneration. Ophthalmology 117:1169–1176PubMedCrossRef
6.
Zurück zum Zitat Smith W, Assink J, Klein R et al (2001) Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108:697–704PubMedCrossRef Smith W, Assink J, Klein R et al (2001) Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108:697–704PubMedCrossRef
7.
Zurück zum Zitat Chakravarthy U, Augood C, Bentham GC et al (2007) Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology 114:1157–1163PubMedCrossRef Chakravarthy U, Augood C, Bentham GC et al (2007) Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology 114:1157–1163PubMedCrossRef
8.
Zurück zum Zitat Curcio CA, Millican CL, Bailey T et al (2001) Accumulation of cholesterol with age in human Bruch’s membrane. Invest Ophthalmol Vis Sci 42:265–274PubMed Curcio CA, Millican CL, Bailey T et al (2001) Accumulation of cholesterol with age in human Bruch’s membrane. Invest Ophthalmol Vis Sci 42:265–274PubMed
9.
Zurück zum Zitat Klein R, Klein BE, Jensen SC et al (1997) The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104:7–21PubMed Klein R, Klein BE, Jensen SC et al (1997) The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104:7–21PubMed
10.
Zurück zum Zitat Tomany SC, Cruickshanks KJ, Klein R et al (2004) Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 122:750–757PubMedCrossRef Tomany SC, Cruickshanks KJ, Klein R et al (2004) Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 122:750–757PubMedCrossRef
11.
Zurück zum Zitat Casparis H, Lindsley K, Kuo IC et al (2012) Surgery for cataracts in people with age-related macular degeneration. Cochrane Database Syst Rev 6:CD006757PubMed Casparis H, Lindsley K, Kuo IC et al (2012) Surgery for cataracts in people with age-related macular degeneration. Cochrane Database Syst Rev 6:CD006757PubMed
12.
Zurück zum Zitat Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417–1436CrossRef Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417–1436CrossRef
13.
Zurück zum Zitat Seddon JM, Cote J, Page WF et al (2005) The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123:321–327PubMedCrossRef Seddon JM, Cote J, Page WF et al (2005) The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123:321–327PubMedCrossRef
14.
Zurück zum Zitat Klaver CC, Wolfs RC, Assink JJ et al (1998) Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 116:1646–1651PubMedCrossRef Klaver CC, Wolfs RC, Assink JJ et al (1998) Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 116:1646–1651PubMedCrossRef
15.
Zurück zum Zitat Scholl HP, Fleckenstein M, Charbel Issa P et al (2007) An update on the genetics of age-related macular degeneration. Mol Vis 13:196–205PubMed Scholl HP, Fleckenstein M, Charbel Issa P et al (2007) An update on the genetics of age-related macular degeneration. Mol Vis 13:196–205PubMed
16.
Zurück zum Zitat Charbel Issa P, Chong NV, Scholl HP (2011) The significance of the complement system for the pathogenesis of age-related macular degeneration – current evidence and translation into clinical application. Graefes Arch Clin Exp Ophthalmol 249:163–174CrossRef Charbel Issa P, Chong NV, Scholl HP (2011) The significance of the complement system for the pathogenesis of age-related macular degeneration – current evidence and translation into clinical application. Graefes Arch Clin Exp Ophthalmol 249:163–174CrossRef
17.
Zurück zum Zitat Hageman GS, Hancox LS, Taiber AJ et al (2006) Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med 38:592–604PubMedCrossRef Hageman GS, Hancox LS, Taiber AJ et al (2006) Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med 38:592–604PubMedCrossRef
18.
Zurück zum Zitat Schmidt S, Klaver C, Saunders A et al (2002) A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet 23:209–223PubMedCrossRef Schmidt S, Klaver C, Saunders A et al (2002) A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet 23:209–223PubMedCrossRef
19.
Zurück zum Zitat Neale BM, Fagerness J, Reynolds R et al (2010) Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A 107:7395–7400PubMedCrossRef Neale BM, Fagerness J, Reynolds R et al (2010) Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A 107:7395–7400PubMedCrossRef
20.
Zurück zum Zitat Chen W, Stambolian D, Edwards AO et al (2010) Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A 107:7401–7406PubMedCrossRef Chen W, Stambolian D, Edwards AO et al (2010) Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A 107:7401–7406PubMedCrossRef
21.
Zurück zum Zitat Schmidt S, Hauser MA, Scott WK et al (2006) Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 78:852–864PubMedCrossRef Schmidt S, Hauser MA, Scott WK et al (2006) Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 78:852–864PubMedCrossRef
22.
Zurück zum Zitat Klein ML, Francis PJ, Rosner B et al (2008) CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology 115:1019–1025PubMedCrossRef Klein ML, Francis PJ, Rosner B et al (2008) CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology 115:1019–1025PubMedCrossRef
23.
Zurück zum Zitat Ho L, van Leeuwen R, Witteman JC et al (2011) Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam study. Arch Ophthalmol 129:758–766PubMedCrossRef Ho L, van Leeuwen R, Witteman JC et al (2011) Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam study. Arch Ophthalmol 129:758–766PubMedCrossRef
24.
Zurück zum Zitat Weismann D, Hartvigsen K, Lauer N et al (2011) Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478:76–81PubMedCrossRef Weismann D, Hartvigsen K, Lauer N et al (2011) Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478:76–81PubMedCrossRef
25.
Zurück zum Zitat Hagstrom SA, Ying GS, Pauer GJ et al (2013) Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology [Epub ahead of print] Hagstrom SA, Ying GS, Pauer GJ et al (2013) Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology [Epub ahead of print]
26.
Zurück zum Zitat Scholl HP, Charbel Issa P, Walier M et al (2008) Systemic complement activation in age-related macular degeneration. PLoS One 3:e2593PubMedCrossRef Scholl HP, Charbel Issa P, Walier M et al (2008) Systemic complement activation in age-related macular degeneration. PLoS One 3:e2593PubMedCrossRef
27.
Zurück zum Zitat Coffey PJ, Gias C, McDermott CJ et al (2007) Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci U S A 104:16651–16656PubMedCrossRef Coffey PJ, Gias C, McDermott CJ et al (2007) Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci U S A 104:16651–16656PubMedCrossRef
28.
Zurück zum Zitat Clark SJ, Perveen R, Hakobyan S et al (2010) Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch’s membrane in human retina. J Biol Chem 285:30192–30202PubMedCrossRef Clark SJ, Perveen R, Hakobyan S et al (2010) Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch’s membrane in human retina. J Biol Chem 285:30192–30202PubMedCrossRef
29.
Zurück zum Zitat Yi X, Ogata N, Komada M et al (1997) Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol 235:313–319PubMedCrossRef Yi X, Ogata N, Komada M et al (1997) Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol 235:313–319PubMedCrossRef
30.
Zurück zum Zitat Hageman GS, Luthert PJ, Victor Chong NH et al (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20:705–732PubMedCrossRef Hageman GS, Luthert PJ, Victor Chong NH et al (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20:705–732PubMedCrossRef
31.
Zurück zum Zitat Combadiere C, Feumi C, Raoul W et al (2007) CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 117:2920–2928PubMedCrossRef Combadiere C, Feumi C, Raoul W et al (2007) CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 117:2920–2928PubMedCrossRef
32.
Zurück zum Zitat Luhmann UF, Robbie S, Munro PM et al (2009) The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci 50:5934–5943PubMedCrossRef Luhmann UF, Robbie S, Munro PM et al (2009) The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci 50:5934–5943PubMedCrossRef
33.
Zurück zum Zitat Francis PJ, Schultz DW, Hamon S et al (2007) Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration. PLoS One 2:e1197PubMedCrossRef Francis PJ, Schultz DW, Hamon S et al (2007) Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration. PLoS One 2:e1197PubMedCrossRef
34.
Zurück zum Zitat Klein R, Klein BE, Knudtson MD et al (2007) Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 114:253–262PubMedCrossRef Klein R, Klein BE, Knudtson MD et al (2007) Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 114:253–262PubMedCrossRef
35.
Zurück zum Zitat Holz FG, Bellman C, Staudt S et al (2001) Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 42:1051–1056PubMed Holz FG, Bellman C, Staudt S et al (2001) Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 42:1051–1056PubMed
36.
Zurück zum Zitat Ambati J, Ambati BK, Yoo SH et al (2003) Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48:257–293PubMedCrossRef Ambati J, Ambati BK, Yoo SH et al (2003) Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48:257–293PubMedCrossRef
37.
Zurück zum Zitat Spaide RF (2006) Rationale for combination therapies for choroidal neovascularization. Am J Ophthalmol 141:149–156PubMedCrossRef Spaide RF (2006) Rationale for combination therapies for choroidal neovascularization. Am J Ophthalmol 141:149–156PubMedCrossRef
38.
Zurück zum Zitat Krzystolik MG, Afshari MA, Adamis AP et al (2002) Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120:338–346PubMedCrossRef Krzystolik MG, Afshari MA, Adamis AP et al (2002) Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120:338–346PubMedCrossRef
Metadaten
Titel
Ätiologie und Pathogenese der altersabhängigen Makuladegeneration
verfasst von
P. Herrmann
F.G. Holz
P. Charbel Issa
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
Die Ophthalmologie / Ausgabe 4/2013
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI
https://doi.org/10.1007/s00347-012-2779-5

Weitere Artikel der Ausgabe 4/2013

Der Ophthalmologe 4/2013 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.